Stocks › MPLT
MapLight Therapeutics MPLT
US equityMarket cap rank #3724
$6.93 +$0.71 (+11.41%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $7.60 +9.67%
Open$6.24
Prev close$6.22
Day range$6.06 – $6.93
Volume502.0K
Market cap$385.14M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts6
Average target$26.80+286.7% vs. price
- Buy 50%
- Hold 50%
Low $13.00Now $6.93Avg $26.80High $43.00
Recent rating changes
The last 20 actions on file set price targets from $13.00 to $52.00, averaging $35.16.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 5 Oct 2026 | Guggenheim | HOLD | – |
| 31 Aug 2026 | Needham | BUY | $43.00 |
| 17 Aug 2026 | Morgan Stanley | HOLD | $21.00 |
| 14 Aug 2026 | LifeSci Capital | BUY | $37.00 |
| 13 Aug 2026 | BMO Capital | BUY | $20.00 |
| 11 Aug 2026 | UBS | HOLD | $13.00 |
| 10 Aug 2026 | UBS | HOLD | $13.00 |
| 28 Jul 2026 | Craig-Hallum | BUY | $25.00 |
| 28 Jul 2026 | Morgan Stanley | HOLD | $21.00 |
| 28 Jul 2026 | H.C. Wainwright | BUY | $26.00 |
| 27 Jul 2026 | LifeSci Capital | BUY | $37.00 |
| 27 Jul 2026 | Needham | BUY | $45.00 |
| 24 Jul 2026 | CCORF | BUY | $43.00 |
| 21 Jul 2026 | UBS | BUY | $52.00 |
| 14 Jul 2026 | LifeSci Capital | BUY | $45.00 |
| 10 Jul 2026 | Needham | BUY | $45.00 |
| 2 Jul 2026 | LifeSci Capital | BUY | $45.00 |
| 25 Jun 2026 | Raymond James | BUY | $46.00 |
| 24 Jun 2026 | Raymond James | BUY | $46.00 |
| 23 Jun 2026 | LifeSci Capital | BUY | $45.00 |
No comments yet — be the first to weigh in on MPLT.
Sign in to join the discussion.